Think outside the box: a case report of utilization of an excimer laser sheath as an intracardiac bioptome.

Bioptome Case report Excimer laser Interventional cardiology Lymphoma Unique approach

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 26 06 2022
revised: 01 11 2022
accepted: 23 02 2023
entrez: 16 3 2023
pubmed: 17 3 2023
medline: 17 3 2023
Statut: epublish

Résumé

Malignant cardiac tumours are rare entities that cause severe morbidity and mortality. Possible treatment options vary between surgical removement, (immuno-) chemotherapy, and palliative care, whilst diagnostic workup comprises of imaging and histopathology analysis. Excimer laser sheaths are a new possibility to extract significant tissue samples to offer adequate treatment. A 67-year-old Caucasian female presented with progressive shortness of breath, new onset of fevers, weight loss, and recurrent night sweats. She showed signs of upper venous stasis.Cardiac imaging revealed an obstructive, hypoperfused right atrial mass superior to the tricuspid valve and a sessile structure at the mitral valve. Guideline-directed therapy for endocarditis was started subsequently.A conventional intracardiac biopsy of the tumour was unsuccessful, but an off-label approach using an excimer laser sheath as bioptome leads to the diagnosis of a diffuse large B-cell lymphoma. Immuno-chemotherapy was commenced, leading to reduction in tumour size and rapid improvement in the quality of life. Intracardiac biopsies are an important piece of the puzzle in the diagnostic workup of cardiac neoplasms. This case report is the first description of the utilization of a laser lead extraction tool as a bioptome for intracardiac tumours. Two imaging modalities (echocardiogram, fluoroscopy), as well as the precise technique of the excimer laser, ensured safety for the patient. Clinical studies are paramount to further evaluate the laser sheath as a possible new instrument in the toolbox of an interventional cardiologist.

Sections du résumé

Background UNASSIGNED
Malignant cardiac tumours are rare entities that cause severe morbidity and mortality. Possible treatment options vary between surgical removement, (immuno-) chemotherapy, and palliative care, whilst diagnostic workup comprises of imaging and histopathology analysis. Excimer laser sheaths are a new possibility to extract significant tissue samples to offer adequate treatment.
Case summary UNASSIGNED
A 67-year-old Caucasian female presented with progressive shortness of breath, new onset of fevers, weight loss, and recurrent night sweats. She showed signs of upper venous stasis.Cardiac imaging revealed an obstructive, hypoperfused right atrial mass superior to the tricuspid valve and a sessile structure at the mitral valve. Guideline-directed therapy for endocarditis was started subsequently.A conventional intracardiac biopsy of the tumour was unsuccessful, but an off-label approach using an excimer laser sheath as bioptome leads to the diagnosis of a diffuse large B-cell lymphoma. Immuno-chemotherapy was commenced, leading to reduction in tumour size and rapid improvement in the quality of life.
Discussion UNASSIGNED
Intracardiac biopsies are an important piece of the puzzle in the diagnostic workup of cardiac neoplasms. This case report is the first description of the utilization of a laser lead extraction tool as a bioptome for intracardiac tumours. Two imaging modalities (echocardiogram, fluoroscopy), as well as the precise technique of the excimer laser, ensured safety for the patient. Clinical studies are paramount to further evaluate the laser sheath as a possible new instrument in the toolbox of an interventional cardiologist.

Identifiants

pubmed: 36923115
doi: 10.1093/ehjcr/ytad107
pii: ytad107
pmc: PMC10010480
doi:

Types de publication

Case Reports

Langues

eng

Pagination

ytad107

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: Samer Hakmi reports grants and personal fees from Boston Scientific, Edwards Lifesciences, Medtronic, Meril, Philips/Spectranetics, and Zoll Medical.

Références

Circ Cardiovasc Interv. 2021 Jul;14(7):e010061
pubmed: 34167332
Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):56-60
pubmed: 24087832
Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):360-361
pubmed: 29049802
JACC CardioOncol. 2020 Jun 16;2(2):293-311
pubmed: 34396236
Europace. 2018 Jul 1;20(7):1217
pubmed: 29566158
Can Med Assoc J. 1982 Jun 15;126(12):1381-6
pubmed: 7044509
J Am Coll Cardiol. 1999 May;33(6):1671-6
pubmed: 10334441
Eur J Cardiothorac Surg. 2017 May 1;51(5):902-905
pubmed: 28137751
Tex Heart Inst J. 2011;38(3):261-2
pubmed: 21720466

Auteurs

Niklas Schenker (N)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, 20099 Hamburg, Germany.

Lukas Kaiser (L)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, 20099 Hamburg, Germany.

Sebastian Bohnen (S)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, 20099 Hamburg, Germany.

Samer Hakmi (S)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, 20099 Hamburg, Germany.

Classifications MeSH